Tumor oxygenation nanoliposome synergistic hypoxia-inducible-factor-1 inhibitor enhanced Iodine-125 seed brachytherapy for esophageal cancer
Source abstract
Abstract
Iodine-125 (125I) brachytherapy has become one of the most effective palliative treatment options for advanced esophageal cancer. However, resistance toward 125I brachytherapy caused by pre-existing tumor hypoxia and hypoxia-inducible factor 1 (HIF-1) signaling pathway activation represents a significant limitation in esophageal cancer treatment. To circumvent these problems, herein, we proposed an innovative strategy to alleviate radioresistance of brachytherapy by co-encapsulating catalase (CAT) and HIF-1 inhibitor-acriflavine (ACF) into the hydrophilic cavities of liposome, termed as "ACF-CAT@Lipo". Under overexpressed H2O2 stimulation in the tumor region, the fabricated ACF-CAT@Lipo can generate an amount of O2 and alleviate tumor hypoxia in vitro and in vivo. Furthermore, cooperating with ACF, the expression of hypoxia-related protein (e.g. HIF-1α, VEGF, MMP-2) are obviously decreased. Importantly, the copious oxygenation and the significant inhibition expression of HIF-1α can further improve the radiosensitivity of 125I brachytherapy and finally realize the eradication of esophageal cancer in vivo. The oxygen enrichment and HIF-1 inhibition function of ACF-CAT@Lipo provides a new strategy to overcome the brachytherapy resistance of esophageal cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Cachexia in patients with oesophageal cancer10.1038/nrclinonc.2015.200 ↗
2. Advances in the curative management of oesophageal cancer10.1038/s41416-021-01485-9 ↗
3. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study10.1111/j.1442-2050.2011.01248.x ↗
4. Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial10.1016/S1470-2045(14)70131-7 ↗
5. Scintigraphic detection of 125I seeds after permanent brachytherapy for prostate cancer10.2967/jnumed.107.046474 ↗
6. The relative biological effectiveness of photon radiation from encapsulated iodine-125, assessed in cells of human origin: I. Normal diploid fibroblasts10.1016/0360-3016(90)90315-B ↗
7. Functionalized selenium nanosystem as radiation sensitizer of (125)I seeds for precise cancer therapy10.1021/acsami.7b07167 ↗
8. Lobaplatin promotes (125)I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway10.1038/s41419-019-1918-1 ↗
9. A robust oxygen microbubble radiosensitizer for iodine-125 brachytherapy10.1002/advs.202002567 ↗
10. Overcoming radioresistance in tumor therapy by alleviating hypoxia and using the HIF-1 inhibitor10.1021/acsami.9b18633 ↗
11. Tumor microenvironment as A "game changer" in cancer radiotherapy10.3390/ijms20133212 ↗
12. Targeting hypoxia in cancer therapy10.1038/nrc3064 ↗
13. Exploiting tumour hypoxia in cancer treatment10.1038/nrc1367 ↗
14. Hypoxia and radiation therapy: past history, ongoing research, and future promise10.2174/156652409788167087 ↗
15. Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy10.1016/j.nantod.2020.100960 ↗
16. High intensity focused ultrasound-responsive and ultrastable cerasomal perfluorocarbon nanodroplets for alleviating tumor multidrug resistance and epithelial-mesenchymal transition10.1021/acsnano.0c07287 ↗
17. Genetically modified bacteria for targeted phototherapy of tumor10.1016/j.biomaterials.2021.120809 ↗
18. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma
19. Catalase-based liposomal for reversing immunosuppressive tumor microenvironment and enhanced cancer chemo-photodynamic therapy10.1016/j.biomaterials.2020.119755 ↗
20. Fluorinated chitosan-mediated intracellular catalase delivery for enhanced photodynamic therapy of oral cancer10.1039/D0BM01898H ↗
21. Smart" delivery of monoclonal antibodies from a magnetic responsive microgel nanocomposite10.1021/acsabm.1c00994 ↗
22. Fluorinated chitosan to enhance transmucosal delivery of sonosensitizer-conjugated catalase for sonodynamic bladder cancer treatment post-intravesical instillation10.1021/acsnano.9b06689 ↗
23. Repurposing of acriflavine to target chronic myeloid leukemia treatment10.2174/0929867327666200908114411 ↗
24. DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine's p53-dependent synergistic anti-tumor efficiency with melphalan10.1016/j.canlet.2016.09.029 ↗
25. Ferric ion driven assembly of catalase-like supramolecular photosensitizing nanozymes for combating hypoxic tumors10.1002/anie.202010005 ↗
26. A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro10.1259/bjr.74.877.740056 ↗
27. Catalase-loaded TaOx Nanoshells as bio-Nanoreactors combining high-Z element and enzyme delivery for enhancing radiotherapy10.1002/adma.201602111 ↗
28. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization10.1073/pnas.0909353106 ↗
29. VEGF in signaling and disease: beyond discovery and development10.1016/j.cell.2019.01.021 ↗
30. New functions for the matrix metalloproteinases in cancer progression10.1038/nrc745 ↗
31. Iodine-125 seed radiation induces ROS-mediated apoptosis, autophagy and paraptosis in human esophageal squamous cell carcinoma cells
32. Combined strategy of radioactive I seeds and salinomycin for enhanced glioma chemo-radiotherapy: evidences for ROS-mediated apoptosis and signaling crosstalk10.1007/s11064-018-2547-2 ↗
33. Chloroquine reverses chemoresistance via upregulation of p21 and autophagy inhibition in ovarian cancer10.1038/s41419-020-03242-x ↗
34. Genetic screen for cell fitness in high or low oxygen highlights mitochondrial and lipid metabolism10.1016/j.cell.2020.03.029 ↗
35. Adhesion-mediated apoptosis resistance in cancer10.1016/j.drup.2009.08.001 ↗
36. Hypoxia-dependent angiogenesis and lymphangiogenesis in cancer10.1007/978-3-030-12734-3_5 ↗
37. The protective roles of ROS-mediated mitophagy on (125)I seeds radiation induced cell death in HCT116 cells10.1155/2016/9460462 ↗
38. 125)I seeds radiation induces paraptosis-like cell death via PI3K/AKT signaling pathway in HCT116 cells10.1155/2016/8145495 ↗